Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease
Status:
Not yet recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This study seeks to bridge these technologies and obtain data regarding the safety and
efficacy of image guided percutaneous needle injection of expanded autologous bone marrow
derived mesenchymal stem cells to symptomatic degenerated intervertebral discs in humans. The
primary outcome will be to assess the safety and efficacy and monitor for adverse events.